Skip to main content
BMC Medical Co., Ltd. logo

BMC Medical Co., Ltd. — Investor Relations & Filings

Ticker · 301367 ISIN · CNE100005WQ4 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 528 across all filing types
Latest filing 2025-09-29 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 301367

About BMC Medical Co., Ltd.

https://www.bmc-medical.com

BMC Medical Co., Ltd. specializes in the development and distribution of diagnostic and therapeutic solutions for sleep-disordered breathing and chronic respiratory conditions. The company’s core product portfolio includes continuous positive airway pressure (CPAP) devices, bilevel positive airway pressure (BPAP) systems, and high-flow oxygen therapy equipment. These are complemented by a range of patient interfaces, including nasal, pillow, and full-face masks. BMC integrates digital health capabilities through cloud-based management platforms, enabling remote data analysis and patient monitoring. By focusing on technical innovation and clinical efficacy, the company provides integrated respiratory care systems designed to improve patient compliance and therapeutic outcomes for conditions such as obstructive sleep apnea and chronic obstructive pulmonary disease.

Recent filings

Filing Released Lang Actions
关于修订《公司章程》、完成工商变更登记并换发营业执照的公告
Board/Management Information Classification · 95% confidence The document is an official announcement from Beijing Ruimait Medical Technology Co., Ltd. regarding changes to the company's business scope, amendments to the Articles of Association, completion of industrial and commercial registration changes, and reissuance of the business license. It references board and shareholder meetings where these changes were approved and details the updated company information post-registration. The document is short (1274 characters) and serves as a formal notification of corporate governance and registration updates rather than a full report or detailed financial disclosure. It does not contain financial statements, earnings data, or detailed management discussion. The content aligns with announcements about governance structure changes and company registration updates. Therefore, the most appropriate classification is "Board/Management Information (MANG)" as it relates to changes in company governance and official registration information.
2025-09-29 Chinese
北京瑞迈特医疗科技股份有限公司章程
Governance Information Classification · 95% confidence The document is a detailed corporate charter or articles of association for Beijing Ruimait Medical Technology Co., Ltd. It includes chapters on company general provisions, business scope, shares issuance and transfer, shareholders and shareholders' meetings, board of directors, senior management, financial accounting system, profit distribution, audit, notices and announcements, mergers, amendments to the charter, and other corporate governance matters. It references laws and regulations such as the Company Law, Securities Law, and Shenzhen Stock Exchange rules. The content is focused on the internal governance structure, shareholder rights and obligations, board and management roles, and procedural rules for meetings and resolutions. There is no indication that this is an annual report, earnings release, or any financial statement. Instead, it is a governance document detailing the company's internal rules and governance practices. Therefore, the appropriate classification is Governance Information (CGR). The document length (15,000 characters) and detailed content support this classification with high confidence.
2025-09-29 Chinese
关于持股5%以上股东及其一致行动人减持股份触及1%整数倍的公告
Major Shareholding Notification Classification · 100% confidence The document is a formal announcement from Beijing Ruimait Medical Technology Co., Ltd. regarding the reduction of shareholding by shareholders holding more than 5% of the company's shares. It details the shareholding changes, the reduction percentages, the methods of share disposal, and compliance with relevant regulations. The document includes specific data on share quantities before and after the reduction and confirms that the reduction is in line with previously disclosed plans. There is no financial statement or report content, but rather a regulatory disclosure about shareholding changes by major shareholders. This fits the definition of a Major Shareholding Notification (MRQ). The document length is 3603 characters, which is consistent with a detailed announcement but not a full financial report.
2025-09-24 Chinese
中国国际金融股份有限公司关于北京瑞迈特医疗科技股份有限公司2025年半年度持续督导跟踪报告
Interim / Quarterly Report Classification · 95% confidence The document is titled as a "2025 Half-Year Continuous Supervision Tracking Report" by a sponsor (China International Capital Corporation) regarding a company (Beijing Ruimaite Medical Technology Co., Ltd.). It details the sponsor's oversight activities, including review of company disclosures, governance, fundraising supervision, and compliance with regulatory requirements. It also reports on issues found and measures taken, company and shareholder commitments, and changes in sponsor representatives. The document is a mid-year report focused on supervision and compliance rather than a full annual report or earnings release. It contains substantive content about the half-year period ending June 30, 2025, and is not merely an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). The document length is under 5,000 characters but contains detailed substantive information, so it is not a report publication announcement or regulatory filing. Hence, the classification is IR with high confidence. H1 2025
2025-09-17 Chinese
2025年第二次临时股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled as a resolution announcement from a company's second extraordinary shareholders meeting in 2025. It details the meeting date, attendance, voting results on specific proposals, and legal opinions confirming the meeting's legality. There is no financial data, earnings information, or report publication mentioned. The content focuses on the official announcement of voting results from a shareholders meeting. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is short and it is not a report itself but an announcement of meeting resolutions and voting outcomes.
2025-09-16 Chinese
北京国枫律师事务所关于北京瑞迈特医疗科技股份有限公司2025年第二次临时股东会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the convening, procedures, and results of a company's 2025 second extraordinary general meeting of shareholders. It details the legality of the meeting's call, attendance, voting procedures, and results. It does not contain financial statements or financial performance data, nor is it a report of financial results or management discussion. It is not an announcement of a report but a legal opinion on a shareholders meeting. This type of document fits best under the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it confirms the legality and results of shareholder voting at a general meeting.
2025-09-16 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.